Microarray Diagnostics Market Analysis & Business Tutorial
This tutorial will be held prior to the Advances in Microarray Technology conference.
This tutorial will be an in-depth presentation and discussion of the market for microarray diagnostics. Steven Bodovitz, Ph.D., an expert in the business of microarrays, will present his new Microarray Diagnostics 2008 report in an interactive session.
Attendees will also have the opportunity of acquiring the new Microarray Diagnostics 2008 report (available end April) or Next-Generation Immunoassays report in the delegate package. The package represents a considerable saving over normal list price. Please click the Registration tab on the left-hand side for pricing options.
Introduction to the Tutorial
Multiplexed diagnostics are at an early stage of development. Some are relatively straightforward combinations of separate analyses, but others are truly multivariate and have the opportunity for first-mover advantage but also the challenge of acceptance by physicians and payers.
At this early stage of development, the strategic possibilities are enormous. Microarrays are the wild west of diagnostics. Successfully navigating the possibilities requires a detailed understanding of the market. You need to know the technologies, competition, unmet needs, trends, regulations, reimbursement and acceptance. You need as broad a perspective as you can find. This tutorial provides the opportunity to learn from an expert analyst with more than 10 years of experience evaluating the business of microarrays and to learn from your peers and colleagues in this rapidly-advancing industry.
Topics Covered in this Tutorial
• Technology overview
• Competitive analysis
• Highlights from comprehensive database of microarray diagnostics
• Opportunities and unmet needs
• Regulatory, reimbursement and physician acceptance challenges
• Primary market research
• Quantitative market model
Who Should Attend
• Any stakeholder in microarrays and/or diagnostics
• Anyone considering becoming a stakeholder in microarrays and/or diagnostics
• Established players and entrepreneurs
• Scientists and businesspeople
Learning Objectives/Themes
• The current state of the market and possible future states
• Interactive discussions, including non-confidential assessments of participants’ optimal strategies